Ad is loading...
GAFFX
Price
$80.09
Change
-$1.35 (-1.66%)
Updated
Nov 15 closing price
IRLSX
Price
$78.15
Change
-$1.80 (-2.25%)
Updated
Nov 15 closing price
Ad is loading...

GAFFX vs IRLSX

Header iconGAFFX vs IRLSX Comparison
Open Charts GAFFX vs IRLSXBanner chart's image
American Funds Growth Fund of Amer F3
Price$80.09
Change-$1.35 (-1.66%)
VolumeN/A
CapitalizationN/A
Voya Russell Large Cap Growth Idx Port S
Price$78.15
Change-$1.80 (-2.25%)
VolumeN/A
CapitalizationN/A
GAFFX vs IRLSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. IRLSX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and IRLSX is a Buy.

FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 298B vs. IRLSX (1.42B). GAFFX pays higher dividends than IRLSX: GAFFX (0.75) vs IRLSX (0.19). GAFFX was incepted earlier than IRLSX: GAFFX (8 years) vs IRLSX (16 years). IRLSX is a more actively managed with annual turnover of: 36.00 vs. GAFFX (31.00). IRLSX has a lower initial minimum investment than GAFFX: IRLSX (0) vs GAFFX (1000000). IRLSX (29.80) and GAFFX (28.41) have marching annual gain over last year. IRLSX return over 5 years is better than : 94.33 vs. GAFFX (54.44).
GAFFXIRLSXGAFFX / IRLSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years16 years-
Gain YTD26.82524.104111%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets298B1.42B21,045%
Annual Yield % from dividends0.750.19396%
Returns for 1 year28.4129.8095%
Returns for 3 years-3.7810.44-36%
Returns for 5 years54.4494.3358%
Returns for 10 yearsN/A242.13-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SEI18.740.53
+2.91%
Solaris Energy Infrastructure Inc
BBD2.380.03
+1.28%
Banco Bradesco SA
RUSHA60.66-0.60
-0.98%
Rush Enterprises
LPCN4.89-0.32
-6.14%
Lipocine
ARQT9.26-0.67
-6.75%
Arcutis Biotherapeutics